The Effect and Prognosis of Qili Qiangxin Capsules Combined with Dapagliflozin in the Treatment of Heart Failure with Reduced Ejection Fraction/XU Wang，LUO Gang，LIANG Huiying.//Medical Innovation of China，2025，22(18)：036-040

    [Abstract]Objective： To investigate the effcacy and prognosis of Qili Qiangxin Capsules combined with Dapagliflozin in the treatmentof heart failure with reduced ejection fraction (HFrEF).Method：A total of 84 patients with HFrEF admited to Ganzhou People's Hospitalfrom May2O22 to August 2023 were randomlydivided into two groups of 42 each using arandom number table method.The control group was treated with Dapagliflozin， while the experimental group was treated with Qili Qiangxin Capsules combined with Dapagliflozin.The efficacy， myocardial marker levels，exercise endurance，ventricular remodeling indicators，adverse reactions，and prognosis between two groups werecompared.Result： The total effective rate of treatment in the experimental group was higher thanthatof thecontrol group( P lt;0.05);cardiac troponin (cTnI)，N-terminal pro-brainnatriuretic peptide (pro-BNP) ......